
PMC:7537304
SARS‐CoV‐2 associated Guillain‐Barre syndrome in 62 patients
Abstract
Abstract
With interest we read the review article by De Sanctis et al. about 18 patients with Guillain‐Barre syndrome (GBS) associated with the SARS‐CoV‐2 infection (COVID‐19) [1]. Acute, inflammatory, demyelinating polyneuropathy (AIDP) was the most frequent subtype of GBS. We have the following comments and concerns.
|
Document structure
projects
Unselected / annnotation | Selected / annnotation | |
|
|
|